Clinical Trial to evaluate the efficacy of Siddha Varmam Therapy (SVT) as an addon therapy to Biomedicine among Diabetes patients
Phase 2
Completed
- Conditions
- Health Condition 1: - Health Condition 2: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2021/02/031407
- Lead Sponsor
- Central council for Research in Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Subjects in Age between 30-60 years of both gender
2. Patients having Fasting blood sugar ranging above 100 and below 200 mg/dl
3. HbA1C ranging above 5.5% below 7.5%
Exclusion Criteria
1. Subjects with the age below 30 years and above 60 years are to be excluded from the study.
2. Pregnant women and planning to be pregnant within six months and lactating mother.
3. Known case of
i. Malignancy
ii. Accelerated Hypertension
iii. Coronary artery disease
iv. CNS disorders
v. Type I Diabetes mellitus
vi. Acute infection or fever
vii. Chronic viral hepatitis or HIV-infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Efficacy of Siddha Varmam therapy on Type II Diabetes Mellitus patients in reducing the FBS, PPBS, HbA1c at baseline, 30, 60, 90 days of treatment.Timepoint: 9 months
- Secondary Outcome Measures
Name Time Method 1. Safety of Siddha Varmam therapy on Type II Diabetes Mellitus patients is assessed by comparing Liver function Test and Renal function Test at baseline, 30, 60, 90 days of treatment. <br/ ><br>2. Siddha diagnostic tool is validated and tested at baseline, 30, 60, 90 days of treatment. <br/ ><br>Timepoint: 9 months